Thermo Fisher Sci…
USUSDThermo Fisher Scientific Inc (MX:TMO) — Industrial Machinery/Components. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- thermofisher.com
- Secteur
- Industrials · Industrial Machinery/Components
- Siège Social
- Waltham, United States
- PDG
- Marc N. Casper
- Employés
- 67 816
- Fondée
- 2006
- Cotée Depuis
- 11.04.2014 (MX:TMO)
- Actions en Circulation
- 369.75 M au 2026-06-27
- Flottant
- 368.82 M
- Capitalisation Boursière
- 241.26 Md USD
- Initiés
- 0.13%
- Investisseurs Institutionnels
- 94.08%
- Secteur d'Activité (SIC)
- Measuring & Controlling Devices, NEC
- Forme Juridique
- XTIQ
- ISIN
- US8835561023
- LEI
- HCHV7422L5HDJZCRFL38
- P/E
- 35.5
- Taux de Distribution
- 9.5%
- FCF
- 7.32 Md USD
- Versements / FCF
- 9%
- Dette
- 42.3 Md USD5.2 ans de FCF
- Ancienneté du Dividende
- 14 ans
- Bénéfices, FCF et dividendes versés — pour les 12 mois précédant 27.06.2026 (le dernier rapport de l'entreprise).
Description
Check out our bioconjugation products including, crosslinkers, PEGylation, biotinylation, and labeling reagents that connect capture surfaces to antibodies, and antibodies to enzymes and dyes used with detection technologies. We offer a wide range of traditional enzymes in glycerol buffer and lyo-ready enzymes that can be used in your kits, bulk supply for fill and finish, custom packaged and labeled to your requirements. How does custom commercial supply help accelerate my time to market? Our team has established an impressive resume of scale-up processes due to the substantial production cycles they have already successfully completed for several products. This experience gives them a better bird’s-eye view of the path to production at larger scales without sacrificing quality. With better expectations and planning, our scale-up manufacturing efforts are often incredibly efficient compared to other organizations. Leveraging our experience in scaling up our own products, and those of partners, we can apply our well-earned knowledge to minimize the risk for your product. Why do I need to involve commercial supply reps early in my development process? While manufacturing experience is a clear focus for our work and teams, it is not the only type of experience we bring to our partnerships. Bringing a product to market requires much more than just making or assembling the product—it also requires know-how to navigate regulatory, legal, and financial elements. When collaborating with our OEM and commercial supply team, we help provide experienced professional advice to support your go-to-market needs. Importantly, your devoted commercial supply business development manager (BDM) will serve as your internal project champion to fully connect our entire team and yours. Do you offer support and training for commercial use products? Your devoted commercial supply business development manager (BDM) will serve as your internal project champion offering support and training through every step of your processes. What makes a commercial partnership more valuable than a transactional relationship? For life science product developers, the trouble starts when a key supplier runs into issues beyond their control, like starting material shortages, increased reagent demand, regulation changes, civil unrest, economic downturn, natural disasters, and disease outbreaks. In truth, it is remarkably difficult to fully insulate your product development from supply chain challenges without comprehensive standing infrastructure that can be quickly mobilized—this an important facet to which Thermo Fisher can support our collaborators. — Extrait du site web de l'entreprise
Dividendes
Thermo Fisher Scientific Inc (TMO) verse des dividendes trimestriels. Par an (12 mois jusqu'au dernier paiement annoncé inclus) : 33.0683 MXN par action (paiements : 4). Cela représente environ 0.28% du cours actuel de l'action. D'après l'historique des paiements, la prochaine date ex-dividende est prévue vers 16.12.2026. Historique des dividendes ininterrompu : 14 ans.
| Date Ex | Versement | Montant | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-09-15 | — | 8.4468 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2026-06-15 | — | 8.4468 MXN | 0.1/0.4 % | trimestriel | MX:TMO |
| 2026-03-13 | — | 8.4468 MXN | 0.1/0.4 % | trimestriel | MX:TMO |
| 2025-12-15 | — | 7.7279 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2025-09-15 | — | 7.7279 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2025-06-13 | — | 7.7279 MXN | 0.1/0.4 % | trimestriel | MX:TMO |
| 2025-03-14 | — | 7.7279 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2024-12-13 | — | 7.0090 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2024-09-13 | — | 7.0090 MXN | 0.1/0.2 % | trimestriel | MX:TMO |
| 2024-06-14 | — | 7.0090 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2024-03-14 | — | 7.0090 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2023-12-14 | — | 6.2902 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2023-09-14 | — | 6.2902 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2023-06-14 | — | 6.2902 MXN | 0.1/0.3 % | trimestriel | MX:TMO |
| 2023-03-14 | — | 6.2902 MXN | 0.1/0.2 % | trimestriel | MX:TMO |
| 2022-12-14 | — | 5.3916 MXN | 0.0/0.2 % | trimestriel | MX:TMO |
| 2022-09-14 | — | 5.3916 MXN | 0.0/0.2 % | trimestriel | MX:TMO |
| 2022-06-14 | — | 5.3916 MXN | 0.1/0.1 % | trimestriel | MX:TMO |
| 2022-03-15 | — | 5.3916 MXN | 0.0/0.1 % | trimestriel | MX:TMO |
| 2021-12-14 | — | 4.6727 MXN | 0.0/0.0 % | trimestriel | MX:TMO |
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| Blackrock Inc. | 8.36% | 30.92 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 24.28 M | 2026-06-30 |
| State Street Corporation | 4.55% | 16.83 M | 2026-06-30 |
| FMR, LLC | 3.81% | 14.08 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.19% | 11.8 M | 2026-06-30 |
| Morgan Stanley | 2.91% | 10.76 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 9.63 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.3% | 8.5 M | 2026-06-30 |
| Geode Capital Management… | 2.27% | 8.38 M | 2026-06-30 |
| Franklin Resources, Inc. | 1.97% | 7.27 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 1.68% | 6.23 M | 2026-06-30 |
| Capital World Investors | 1.68% | 6.2 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 4.95 M | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 4.81 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 4.55 M | 2026-08-31 |
| Fidelity Contrafund | 1.06% | 3.91 M | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 3.54 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 2.67 M | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.56% | 2.06 M | 2026-06-30 |
| VANGUARD INSTITUTIONAL I… | 0.55% | 2.02 M | 2026-06-30 |
| CASPER MARC N (Chief Exe… | ≈0.04% | 140 225 | 2026-08-24 |
| LAGARDE MICHEL (Chief Op… | ≈0.02% | 86 347 | 2026-02-25 |
| SPERLING SCOTT M (Direct… | ≈0.02% | 69 479 | 2026-05-20 |
| WILLIAMSON STEPHEN (Chie… | ≈0.01% | 46 095 | 2026-02-25 |
| PETTITI GIANLUCA (Presid… | ≈0.01% | 23 216 | 2026-08-31 |
| SHAFER MICHAEL D (Office… | ≈0.01% | 20 994 | 2026-08-11 |
| LOWERY FREDERICK M. (Off… | ≈0% | 17 133 | 2026-02-25 |
| CHAI NELSON J (Director) | ≈0% | 15 316 | 2026-05-20 |
| BRITT LISA P (Officer) | ≈0% | 14 784 | 2026-08-19 |
| BOXER MICHAEL A (General… | ≈0% | 10 815 | 2025-03-10 |
